Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — Defibrotide benefitted adults and pediatric patients with severe or very severe veno-occlusive ...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) yesterday issued a negative opinion on Gentium SpA's marketing application for defibrotide (Defitelio) for ...
DUBLIN, April 29, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that enrollment in the Phase 3 clinical study of defibrotide for the prevention of hepatic veno-occlusive ...
Measuring mercaptopurine (6MP) adherence using red cell 6MP metabolite levels in children with acute lymphoblastic leukemia (ALL): A COG AALL03N1 study. This is an ASCO Meeting Abstract from the 2017 ...
Better survival with fludarabine and timed sequential busulfan regimen in older patients with AML/MDS. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not ...
Doctors are one step closer to having a risk biomarker to alert them to which of their pediatric stem cell transplant patients are likely to experience a potentially deadly side effect called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results